January 2026 Pre-Funded Warrants (registered direct, )
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
SXTC$2.86+2.88%
China SXT Pharmaceuticals, Inc.
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CNExchange: Nasdaq
Mkt Cap:$1.96M
Float & O/S:
Inst Own:
DilutionScan read 37 of China SXT Pharmaceuticals, Inc.'s SEC filings and found 7 warrant series, 1 convertible, 1 ATM program, 1 equity line, 3 shelf registrations and 6 completed offerings on file for SXTC. The latest dilution event on file is an offering on Oct 9, 2026. Analysis updated Oct 26, 2026.
Signal8 Summary
SXTC
Collapsing revenue and massive dilution
Snapshot
China SXT is a tiny micro-cap with a shrinking business. FY 2026 revenue dropped 38% to $1.1M while net losses widened to $6.2M, meaning the company lost over five dollars for every dollar it brought in. Gross margins fell to 17%.
What's Happening Right Now
- : The company closed a $9 million registered direct offering that includes warrants allowing holders to receive shares without cash payment if the price falls, potentially adding 63 million new shares.
- : The company announced a 1-for-80 share consolidation effective August 10, 2026 to maintain its Nasdaq listing.
- : China SXT entered an agreement to sell up to $100 million of its Class A ordinary shares through an at-the-market offering program.
Raise routes on file: active ATM + effective shelf + active equity line · latest dilution event 25 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Oct 9, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Outstanding
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
July 2026 Registered Direct Ordinary Warrants ( zero price option)
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
October 2026 Registered Direct Ordinary Warrants ( zero price option)
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
ATM program
Issued 2026
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
Equity line
Issued 2026
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
F-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
F-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
F-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Registered direct offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Registered direct offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Registered direct offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Registered direct offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your SXTC trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
